arrow
C

Cheng-Hao Tseng

e-da cancer hospital
H指数:24
被引数:1,762

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety, Tolerability, and Pharmacodynamics of GS-4224 in Healthy Participants and Participants With Chronic Hepatitis B

GS-4224在健康受试者和慢性乙型肝炎患者中的安全性、耐受性和药效学研究

2026-05-210
PRE
Long-Term Mortality Following Hepatitis C Cure in a Real-World Multinational Cohort

丙型肝炎治愈后的长期死亡率:一项真实世界跨国队列研究

2026-02-220
PRE
Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment Response to Nucleos(t)ide Analogs

合并脂肪性肝病和慢性乙型肝炎对核苷(酸)类似物治疗反应的影响

2025-10-010
PRE
Overall and Stratified Accuracies of H. pylori Serology Testing: A Multicenter Study of 8497 Screening-Naïve Adults

幽门螺杆菌血清学检测的总体和分层准确率:一项涉及8497名筛查前成人的多中心研究

2025-09-210
PRE
Impact of metabolic dysfunction on treatment responses to nucleos(t)ide analogues in chronic hepatitis B: a retrospective multi-center REAL-B cohort study

代谢功能障碍对核苷(酸)类似物治疗慢性乙型肝炎反应的影响:一项回顾性多中心REAL-B队列研究

2025-08-110
PREAI
Distribution, Characteristics, and Natural History of Diverse Types of Indeterminate Chronic Hepatitis B: A REAL-B Study

不同类型的不确定慢性乙型肝炎的分布、特征及自然史:REAL-B研究

2025-05-210
PRE
Real-world Effectiveness and Tolerability of Interferon-free Direct-acting Antiviral for 15,849 Patients with Chronic Hepatitis C: A Multinational Cohort Study
2024-06-170
OAAI
Bleeding Risk of Cold Versus Hot Snare Polypectomy for Pedunculated Colorectal Polyps Measuring 10 mm or Less: Subgroup Analysis of a Large Randomized Controlled Trial
2024-05-092
OAAI
Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study
2024-03-012
PRE
Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection

selgantolimod在慢性乙型肝炎病毒感染的病毒病患者中的安全性,药效学和抗病毒活性

2024-02-011
OAAI
Racial and ethnic disparities in untreated patients with hepatitis C virus-related hepatocellular carcinoma but not in those with sustained virologic response
2024-01-035
PRE
Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study

慢性乙型肝炎患者改用替诺福韦艾拉酚胺后脊柱骨密度增加:一项前瞻性多中心研究

2023-10-264
PRE